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The early events in the cardiac hypertrophic process induced by hemodynamic load include activation of B-type natriuretic peptide (BNP) and
c-fos gene expression. However, it is unknown whether stretch acts directly or through local paracrine factors to trigger changes in cardiac gene
expression. Herein we studied the involvement of endothelin-1 (ET-1) and angiotensin II (Ang II) in load-induced activation of left ventricular
BNP and c-fos gene expression using an in vitro stretch model in isolated perfused adult mice hearts. Two-hour stretch induced by increasing
coronary flow rate from 2 to 5 ml/min increased the expression of BNP and c-fos genes by 1.9- and 1.5-fold, respectively (P<0.001 and P<0.05).
A mixed ETA/B receptor antagonist bosentan attenuated the BNP gene expression response to load by 58% (P<0.005). A similar 53% inhibition
was observed with the selective ETA receptor blocker BQ-123 (P<0.05). Type 1 Ang II receptor antagonist CV-11974 decreased the activation of
BNP gene expression by 50% (P<0.05). In contrast, the activation of c-fos gene expression was not inhibited by antagonists of ETA/B and AT1
receptors. Our results show that ET-1 and Ang II play a key role in the induction of BNP, but not c-fos gene expression in response to load in intact
adult murine hearts.
© 2006 Elsevier B.V. All rights reserved.Keywords: Vasoactive peptides; Ventricular stretch; Hypertrophy; Cardiac overload1. Introduction
Pressure overload triggers various adaptive mechanisms in
the heart to meet the increased demands. Rapidly after the onset
of load, contractile force is increased through the Frank–
Starling mechanism followed by a delayed, slow increase in
force (slow force response, Anrep effect) [1,2]. If hemodynamic
overload is sustained the myocardium undergoes hypertrophic
growth and the increased wall thickness normalizes wall stress
and thereby contributes to the maintenance of left ventricular
function [3]. The hypertrophic process is characterized by
specific changes in cardiac gene expression. Acute hemody-
namic overload has been shown to induce a rapid increase in the
left ventricular expression of several proto-oncogenes, such as
c-fos and c-jun [4]. Moreover, the expression of B-type
natriuretic peptide (BNP) gene takes place with many char-⁎ Corresponding author. Tel.: +358 8 537 5236; fax: +358 8 537 5247.
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doi:10.1016/j.bbadis.2006.11.004acteristics of an immediate-early gene. Indeed, mechanical
stretch and vasopressin- and phenylephrine-induced hemody-
namic overload in the left ventricle have been shown to result in
an increase in the BNP gene expression within 1 h [5,6]. These
changes are later followed by reactivation of fetal genes
including atrial natriuretic peptide (ANP), β-myosin heavy
chain, and skeletal muscle α-actin [4,6,7]. Mechanical stretch of
cultured cardiac myocytes causes release of angiotensin II (Ang
II) and endothelin-1 (ET-1), which in turn can induce genetic
reprogramming and hypertrophic growth. However, it has not
yet been established whether stretch acts directly or through
local paracrine and autocrine factors liberated in response to
hemodynamic load to trigger changes in cardiac gene expres-
sion. ET-1 and Ang II have been implicated in stretch-induced
early activation of BNP gene expression in cultured rat
cardiomyocytes [8] and isolated perfused rat heart preparation
[9]. On the other hand, endothelin A/B (ETA/B) receptor
antagonist bosentan and Ang II type 1 (AT1) receptor antagonist
losartan failed to inhibit the early activation of left ventricular
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a rat model [10]. Although genetically engineered mice have
been used as disease models at large scale, it is unknown if these
paracrine factors are involved in the early phase gene expression
responses induced by cardiac overload in the adult, intact
murine heart.
In the present study, to examine stretch-induced changes in
cardiac gene expression, we applied an in vitro stretch model in
isolated perfused adult mice hearts. Elevating aortocoronary
perfusion augments coronary perfusion pressure [11] and
thereby stretches and thickens the ventricular wall [12].
Immediately, contractile force and oxygen consumption are
increased, a response known as the Gregg effect [11]. Moreover,
elevated perfusion pressure accelerates protein synthesis in the
heart independent of greater cardiac work, development of
intraventricular pressure or energy availability [11–14]. In rat
heart, elevated perfusion pressure induces the expression of the
early response genes, such as c-fos and BNP [15]. Increased
coronary flow rate stimulates capillary endothelium, which
through paracrine mediators is able to regulate cardiomyocyte
function [16,17]. Previously, we have shown that ET-1, but not
Ang II, is a key mediator of the contractile response to elevated
coronary perfusion in isolated mice hearts [18]. To test the
hypothesis that ET-1 or Ang II are involved in the regulation of
acute cardiac gene expression response to increased load, ETA-,
mixed ETA/B- andAT1 receptor antagonists were used.We report
that the cardiac expression of BNP and c-fos was upregulated in
mice hearts imposed to elevated coronary perfusion. Further-
more, both local ET-1 and Ang II are involved in the
upregulation of BNP but not c-fos gene expression in response
to increased load in intact mice hearts.
2. Materials and methods
2.1. Experimental animals
Male NMRImice (10–13 wk of age) obtained from the Experimental Animal
Center at the University of Oulu were used for the studies with increased
coronary flow rate. The body weight of the mice was 43 g (n=137). The Animal
Use and Care Committee of the University of Oulu approved the experimental
design.
2.2. Drugs
The following drugs were used: bosentan, BQ-123, CV-11974 and ET-1.
Bosentan was generously supplied by Dr. Martine Clozel, Hoffmann-La Roche
(Basel, Switzerland) and Actelion (Allschwil, Switzerland) and CV-11974 by
Dr. Hajime Toguchi, Takeda Chemical Industries (Osaka, Japan). BQ-123 and
ET-1 were from Phoenix Pharmaceuticals.
2.3. Isolated, perfused mouse heart preparation
The isolated, perfused mouse heart preparation was similar as previously
described [18]. After initialization of retrograde aortic perfusion the hearts
were perfused at a constant flow rate of 2 ml/min with a peristaltic pump
(model 312, Minipuls 3) for 50 min (equilibration period). Heart rate was
maintained steady (400 beats/min) by atrial pacing with a Grass stimulator
(8 V, 0.5 ms; model S88, Grass Instruments). Variations in perfusion pressure
were measured with a pressure transducer (model MP-15, Micron Instruments)
situated on a sidearm of the aortic cannula. All recordings were made with a
Grass 7DA polygraph. At the end of the experiment the left and rightventricles were cut separate, weighed, snap frozen in liquid nitrogen and
stored in −70 °C until analyzed.
2.4. Experimental design
In the first set of experiments, the level of load required to activate gene
expression in mouse hearts was tested by increasing the coronary flow rate
after the equilibration period to 4, 5, or 6 ml/min by increasing the rate of the
peristaltic pump step by step over a 2 min period. In the experiments
characterizing the role of ET-1 and Ang II in responses to elevated flow rate,
the 50-min equilibration period was followed by 10 min of pretreatment with
vehicle, bosentan (1 μM; mixed ETA/B receptor antagonist), BQ-123
(100 nM; selective ETA receptor antagonist), or CV-11974 (10 nM; Ang II
type 1 (AT1) receptor antagonist). Thereafter, the infusion was continued and
the coronary flow rate was increased from 2 to 5 ml/min for 2 h. Previous
studies have shown that these concentrations of the antagonists effectively
block the responses mediated by the respective receptors in isolated hearts
[18–20].
2.5. Isolation and analysis of cytoplasmic RNA
RNA was isolated from ventricles by the guanidine thiocyanate-CsCl
method [21]. For the RNA Northern blot analyses, 10 μg samples of the RNA
were transferred to Amersham Hybond N+ nylon membranes. A full-length
mouse BNP cDNA probe [22] (a generous gift from Dr. Yoshihiro Ogawa,
Kyoto University School of Medicine, Kyoto, Japan), full length rat ANP
cDNA probe [23] (a generous gift from Dr. Peter L. Davies, Queen's
University, Kingston, Canada), cDNA probe made by RT-PCR for rat c-fos
(nucleotides 231–1280) and cDNA probe complementary to rat 18S
ribosomal RNA were labeled with [32P]-dCTP with T7 Quick Prime Kit
(Pharmacia LKB Biotechnology) and the membranes were hybridized and
washed as described previously [15]. The rat probes used showed over 95%
homology with respective mouse sequences and a single mRNA species for
ANP and c-fos, respectively, was identified in Northern blots. Membranes
were exposed to Phosphor screens and scanned with Phosphor Imager
(Molecular Dynamics). The hybridization signal was normalized to that of
18S mRNA for each sample. For ET-1 mRNA level analysis, quantitative RT-
PCR was used as described [24]. The primer and probe sequences used for
prepro-ET-1 analysis were: Forward 5′-ATGGACAAGGAGTGTGTC-
TACTTCTG-3′; Reverse 5′-GGGACGACGCGCTCG-3′; Probe 5′-Fam-
CACCTGGACATCATCTGGGTCAACACTC-Tamra-3′. The sequences for
18S analysis were: Forward 5′-TGGTTGCAAAGCTGAAACTTAAAG-3′;
Reverse 5′-AGTCAAATTAAGCCGCAGGC-3′; Probe 5′-Vic-CCTGGTGG-
TGCCCTTCCGTCA-Tamra-3′.
2.6. Statistics
Results are expressed as means±SE. Student's t-test was used for
comparison between two groups. One-way ANOVA followed by post hoc test
for least significant differences was used for comparisons with multiple groups.
Differences at the 95% level were considered statistically significant.3. Results
3.1. Activation of BNP gene expression in response to elevated
load in mice hearts
Elevation of coronary flow from the baseline of 2 ml/min to
4, 5 or 6 ml/min for 2 h resulted in a significant increase in BNP
mRNA levels (Fig. 1, P<0.05 vs. 2 ml/min). The coronary flow
rate of 5 ml/min produced the maximal 1.9±0.1-fold increase in
BNP gene expression (P<0.001, Fig. 1). Therefore, this flow
rate was chosen for further experiments. The changes in cardiac
BNP gene expression induced by elevated coronary flow rate
Fig. 1. A representative Northern blot and a bar graph showing left ventricular
BNPmRNA levels after 2 h of loading with different levels of coronary flow rate
or 1 nM ET-1 (with flow rate of 2 ml/min). n=8 for each group with different
flow rate, n=12 for ET-1. *P<0.05, †P<0.001 vs. 2 ml/min group.
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namic loading in vivo [10].
3.2. ET-1 and Ang II mediate the load-induced activation of
BNP gene expression
A significant attenuation of the BNP gene expression
response to elevated load was observed in both ET-1 receptor
and AT1 receptor antagonist treated hearts at 2 h. Mixed ETA/B
receptor antagonist bosentan attenuated the BNP gene expres-
sion response to load by 58±11% (Fig. 2, P<0.005), while AT1
antagonist CV-11974 inhibited the induction of BNP geneFig. 2. Representative Northern blots and respective bar graphs showing the effect of A
gene expression responses. Veh, Vehicle; B, Bosentan; C, CV-11974; BQ, BQ-123. Pa
elevated load treated with vehicle.expression by 50±10% (P<0.05). Moreover, corresponding
(53±10%) attenuation of the load-induced BNP response was
seen with the selective ETA receptor blocker BQ-123 (P<0.05).
Combined administration of bosentan and CV-11974 resulted in
65±7% smaller BNP response to load compared to vehicle
infusion (Fig. 2, P<0.01). However, even the combination was
not able to completely prevent the activation of BNP gene
expression in response to elevated coronary perfusion (P<0.05
vs. vehicle treated hearts perfused with 2 ml/min). Furthermore,
there was no statistically significant difference in BNP mRNA
levels between the bosentan plus CV-11974 treated hearts
compared to the hearts treated with either of these agents alone
(Fig. 2). Similarly to previously reported results [10], ETA/B,
ETA, or AT1 receptor antagonists had no effects on left
ventricular BNP mRNA level under baseline conditions (with-
out an elevated load).
3.3. ET-1 and Ang II are not involved in the load-induced
activation of c-fos gene expression
Using the flow rate of 5 ml/min, the left ventricular c-fos
mRNA levels were increased 1.5±0.2-fold compared to the
baseline after 2 h loading (Fig. 2, P<0.05). In contrast to the
BNP response, the load-induced changes in c-fos gene
expression were not affected by the drug treatments (Fig. 2).
There were no significant treatment effects on c-fos mRNA
levels in either loaded or unloaded mice hearts.
3.4. The effect of elevated coronary flow rate on left ventricular
ET-1 and ANP gene expression
Since ET-1 appeared to be a major contributor to acute
responses to elevated load in isolated perfused mice hearts, we
next analyzed the changes in left ventricular preproET-1 mRNA
levels after 2-h loading. Left ventricular preproET-1 mRNAng II or ET-1 receptor antagonists on load induced left ventricular BNP and c-fos
nel A, BNP. Panel B, c-fos. *P<0.05, **P<0.01 vs. vehicle control; †P<0.01 vs.
Table 1
Hemodynamic parameters in isolated mice hearts at the end of the experiments
n Heart rate
(beats per minute)
Perfusion
pressure (mm Hg)
Developed
tension (g)
Control
Vehicle 10 399±1 44±5 0.50±0.08
BQ-123 6 399±1 37±2 0.49±0.08
Bosentan 10 398±1 52±5 0.44±0.11
CV-11974 8 400±1 40±5 0.41±0.06
Bosentan+CV-11974 8 400±2 51±7 0.40±0.06
Load
Vehicle 8 400±1 167±12 0.35±0.03
BQ-123 6 399±1 136±18 0.48±0.12
Bosentan 12 401±1 160±11 0.43±0.12
CV-11974 8 401±1 143±17 0.30±0.06
Bosentan+CV-11974 9 400±1 149±19 0.49±0.17
Values are mean±SE. The parameters did not differ significantly from the
respective vehicle treated group (One-way ANOVA followed by a post hoc test
for least significant differences).
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(Fig. 3, P<0.05). This increase in ET-1 mRNA levels was
unaffected by bosentan and CV-11974 treatments (1.8±0.2 and
2.4±0.4-fold increases compared to control, respectively,
P=NS vs. vehicle infused loaded hearts, P<0.01 vs. vehicle
infused control). Left ventricular ANP mRNA levels remained
unchanged after acute, 2-h loading (Fig. 3), in agreement with
previous studies showing different regulation of ANP gene
expression compared to BNP and c-fos [7,15,25,26].
3.5. Effects of the drug treatments on perfusion pressure
The perfusion pressure was continuously monitored to
measure vasoactive effects of the drugs (Table 1). Since no
differences were noted, we conclude that the changes in the
gene expression by drug treatments did not arise from altered
level of mechanical stimulation of the hearts. Moreover, at the
end of the 2-h experimental period, no differences were
observed in the contractile performance of the hearts, as
measured by developed tension (Table 1).
4. Discussion
Our results show that the elevated coronary perfusion (Gregg
phenomenon) is coupled with acute changes in gene expression
in mice hearts. Furthermore, we show that the paracrine
regulators ET-1 and Ang II are the key mediators of the BNP
gene expression response to load in mice hearts. The ETA
receptor subtype is mainly responsible for mediating the effects
of ET-1, since ETA antagonist BQ-123 produced similar
attenuation of the load induced BNP gene expression as the
mixed ETA/B antagonist bosentan. Under these experimental
conditions, the regulation of c-fos gene expression in response
to hemodynamic stress differed from that of BNP, being
independent of both ET-1 and Ang II.
The activation of the early response genes in response to
hemodynamic load is an early event in the series of changes
leading to left ventricular hypertrophy and heart failure.
Thus, understanding the molecular regulation of the early
load-induced responses may potentially help to develop novel
treatments for heart failure. c-fos and BNP are upregulatedFig. 3. PreproET-1 and ANP mRNA levels in the left ventricles of isolated
mouse hearts subjected to loading with elevated coronary flow rate. mRNA
results are expressed as ratio to 18S determined by Northern blot analysis (ANP)
or quantitative reverse transcription-PCR analysis (preproET-1). *P<0.05 vs.
control.very early, while the induction of ANP gene expression in
the overloaded left ventricle occurs later [25–28]. Mechanical
stretch is coupled with the cellular release of Ang II and
ET-1, which have been reported to act as chemical mediators
of stretch-induced myocyte hypertrophy and BNP gene
expression [8,29]. Recently, a number of well-designed
studies have provided further evidence supporting a role for
cardiac ET-1 in LVH and heart failure in mice. Conditional
cardiac overexpression of ET-1 was shown to lead to dilated
cardiomyopathy and increased mortality in mice [30]. In
agreement with this, cardiomyocyte-specific inactivation of
ET-1 gene was able to prevent LVH after stimulation with
tri-iodothyronine [31]. However, mice with cardiomyocyte-
specific knockout of ETA receptor were not resistant to
cardiac hypertrophy induced by Ang II or isoproterenol [32].
Thus, it appears that locally produced ET-1 plays a key role,
but is not obligatory in the process of LVH and heart failure
in mice.
Several experimental studies have also suggested a role for
ET-1 and Ang II in the responses to acute cardiac overload
[8,29,33–36]. Yet, other studies have shown that they are not
obligatory for acute induction of left ventricular gene expression
or even for the development of LVH [9,10,32]. ET-1 and Ang II
have been reported to potentiate each other's effects, and they
may act in chain, Ang II inducing the ET-1 release [8,37,38].
Moreover, exogenously administered ET-1 and Ang II are
potent stimuli of BNP gene expression and LVH [6,39].
Although our present observation of ET-1 and Ang II
dependence of left ventricular BNP gene expression response
to load supports their role in the hypertrophic process in mice
hearts, our data also shows that there is additional, bosentan-
and CV-11974-insensitive mechanisms, involved in transducing
mechanical load to responses in the gene expression; even
combining the antagonists of both ET and Ang II systems did
not block the BNP gene expression response completely, and
they had alone or in combination no effect on c-fos gene
expression. In the experimental model employed in the current
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other's effects, as combined antagonism of both ETA/B and AT1
receptors did not provide significant additional effect on the
BNP gene expression responses compared to treatment with
either antagonist alone.
Analogous to the gene expression responses, the paracrine
mediators ET-1 and Ang II are important mediators of the
contractile responses to load. In the rat, the slowly developing
part of contractile response to stretch is mediated by ET-1 and
Ang II, leading to activation of Na+/Ca2+-exchanger in reverse
mode, increasing intracellular Ca2+ as a final mechanism
resulting in positive inotropism [40]. Similar mechanism
suggesting a role for ET-1 and Ang II in the slow force
response has been described in feline cardiac tissue [37]. On the
other hand, in the ferret heart, the slow force response was
mediated by ET-1 but not Ang II [41]. A recent study with strips
from failing human myocardium showed that although a slow
force response similar to the rat heart exists, Ang II and ET-1 are
not obligatory mediators [42]. Earlier, the load induced slow
force response in rabbit hearts has also been reported to be
independent of ET-1 and Ang II [43]. We have reported a
significant contribution of ET-1 but not Ang II to contractile
response associated with elevated coronary perfusion in mice
hearts [18]. Thus, there appears to be potentially significant
interspecies differences in the role of ET-1 and Ang II in acute
cardiac responses to elevated load.
The present experimental model of cardiac overload utilizes
the elevation of coronary flow rate as a loading stimulus. The
elevation of coronary perfusion pressure stretches the left
ventricular wall [11–14]. Since the wall stretch is a predominant
determinant of BNP gene expression [6], the wall tension may
contribute directly to the effect of elevated aortic perfusion
pressure on cardiac gene expression. The primary event in the
mechanosensing process in response to elevated rate of
perfusion has been suggested to be the activation of the stretch
activated ion channels, yet this is not thoroughly understood at
present [44]. Our results support the model that the mechanical
stimulus is able to activate ET-1 and Ang II signaling, which
then are responsible in part, but not solely, for the load-
responses at the gene expression level.
The elevation of coronary flow rate is likely to produce
effects also on the function of endothelium, in addition to
direct stretch on the ventricular wall. This hypothesis is
supported by the ability of shear stress to activate multiple
signaling cascades in endothelial cells [45,46]. Furthermore,
endothelial cells are able to respond to altered levels of stress
by changing the secretion of vasoactive factors which are
potent regulators of cardiac function including ET-1 [17,47].
Capillary perfusion and ET-1 regulate contractile response to
elevated coronary perfusion in different models [16,18].
Underscoring the significance of ET-1 in cardiac responses
to mechanical load, the ET-1 mRNA levels were increased in
response to elevated coronary perfusion pressure. The present
experimental model does not allow the analysis of the cell
types responsible for the expression of ET-1 (and Ang II). In
myocardium, endothelial cells are the primary site of ET-1
production, but also fibroblasts, cardiomyocytes and evensmooth muscle cells possess the ability to synthesize ET-1
[39]. While both ET-1 and Ang II are able to stimulate ET-1
gene expression [39], they did not account for the elevated
level of preproET-1 mRNA based on the inability of bosentan
and CV-11974 to attenuate the response. Thus, direct stretch of
ventricular wall or shear stress induced by elevated coronary
flow may explain elevated ET-1 observed in the present study.
Previously, a transient increase in ET-1 mRNA levels in
response to elevated shear stress in cultured endothelial cells
has been reported [46,47]. Furthermore, the long-term cardiac
overload imposing stretch on the ventricular wall is a known
stimulus for ET-1 synthesis and secretion [39]. The gene
expression of the renin–angiotensin system components is
regulated more slowly in response to load and thus it was out
of the scope of the present study [48].
The regulation of c-fos gene expression appears to differ
from that of BNP, since ETA/B or AT1 receptor blockade had
no effect on load induced increase of c-fos mRNA levels. This
supports the concept that multiple pathways are involved in
mechanotransduction process induced by cardiac overload.
The differential regulation of BNP and c-fos may be related to
the transcription factors responsible for activating the genes.
An analysis of the promoter of the rat BNP gene has indicated
the presence of a proximal activator element that is composed
of an activator protein-1 (AP-1) like element, an M-CAT
(transcription enhancer factor-1) and two GATA elements
[28]. Recently, we have found in stretched culture of cardio-
myocytes that mutation of GATA binding sequence of BNP
promoter inhibited stretch-response by 40%, and that it was
almost completely abolished when GATA mutation was
combined with Nkx-2,5 binding element mutation [49]. In
contrast to BNP, the promoter region of the c-fos gene does
not contain any GATA binding sites [50], and the main
transcription factors responsible for c-fos gene regulation are
thought to be serum response factors and ternary complex
factors including Elk-1, SAP-1 and cAMP response element
binding protein [50].
Based on our results elevated mechanical load through
increased coronary flow increases expression of BNP, c-fos and
preproET-1 in mouse left ventricular myocardium. The increase
of BNP mRNA was inhibited by ET-1 and Ang II receptor
antagonists. Moreover, our study revealed an ET-1- and Ang II-
independent component of the BNP gene expression in
response to elevated coronary flow rate. In conclusion, these
results provide evidence of the pivotal role of paracrine/
autocrine mediators in gene expression response to elevated
load in mice hearts.
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